Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer.
Krongrad
A
A
Brady
J
J
Rodriguez
R J
RJ
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D010166:Palliative Care; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D013739:Testosterone / Q000097:blood*; D017211:Treatment Failure
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D013739:Testosterone; D017430:Prostate-Specific Antigen